Product Code: RP-ID-10086156 |
Published Date: 21 Oct 2022 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10086156
Market Overview:
Global Dermal Fillers Market: Analysis By Product Type (Biodegradable and Non-Biodegradable), By Material (Hyaluronic Acid, Poly-l-Lactic Acid, Calcium Hydroxylapatite, PMMA and Others), By Application (Facial Line Correction, Lip Enhancement and Others), By Region, By Country Opportunities and Forecast 2022-2030
"The global dermal fillers market is anticipated to expand at a CAGR of ~3% over the period 2022-2030, registering the revenue of USD ~4 billion by the end of 2021. With the help of dermal filler products, various skin-related problems can be treated. Dermal filling procedures can be used to remove wrinkles, scars, skin smoothing and other procedures. Despite the fear of side effects, the growth of this market may be slow; however, the market has grown in recent years due to better availability of facilities and technological advancements and an increasing ageing of the population.
Dermal fillers are soft gel-like substances injected under the skin. They can solve many common problems, such as diminishing dark circles under the eyes, lifting cheekbones, plumping lips, smoothing lip lines and nasolabial folds (wrinkles from the side of the nose to the corners of the nose). .) And rejuvenation of hands.
Dermal fillers can be composed of a variety of substances, some are naturally occurring and some are synthetic. One of the most common compounds used in dermal fillers is hyaluronic acid (HA). Hyaluronic acid is a substance naturally present in human skin and plays an important role in maintaining skin moisture and plumpness. HA fillers, depending on their specific chemical composition, can last six months to longer before being gradually absorbed by the body.
COVID 19 SCENARIO ANALYSIS :
Pharmaceutical and biotechnology companies are working with governments around the world to respond to the COVID-19 outbreak, from supporting vaccine development to planning for supply chain challenges. Currently, there are approximately 115 candidate vaccines and 155 molecules in the development process. In addition, the demand for commonly used drugs such as hydroxychloroquine to treat COVID-19 has increased sharply. Such high demand for these drugs provides a huge opportunity for manufacturers of drugs to control COVID-19 because many developed countries lack these drugs. Due to the demand for vaccines and drugs to treat COVID-19, the pharmaceutical and biotechnology industries are expected to experience significant growth in the future. Considering these factors, COVID-19 is expected to have a significant impact on the dermal filler market.
MAIN INFLUENCING FACTORS :
The general population’s demand for dermal fillers is one of the key factors driving the growth of the global dermal fillers market. The R&D program in the dermal filler industry has increased, and has recently received regulatory approval. Therefore, this has a positive contribution to the growth of the market. The high proportion of the elderly population and the increase in premature aging due to environmental factors such as pollution are the reasons for the market growth. Dermal fillers are being commonly used to increase. To achieve fuller lips for women. In addition, fillers give lips a natural appearance at an affordable cost, so they are expected to be quickly adopted by the market in the future.
GROWTH FACTORS :
The dermal filler market is emerging due to fewer methods of treating various types of pain. problem. Related to facial skin, the incidence of diseases that occur after surgery is lower, the degree of pain is lower, there are fewer scars, and smaller incisions are required. The market for dermal fillers is not limited to facial skin surgery, but also includes treatments that aesthetically alter body parts. The increase in population aging has led to an increase in the demand for anti-aging treatments. This treatment also helps to rejuvenate the skin and restore the collagen lost in the body. These factors have promoted the growth of the market. In addition, the high costs associated with skin filling procedures and side effects such as skin redness, bruising, and granulation can also hinder market growth.
NEW PRODUCT RELEASE :
In September 2019, Allergan plc. announced that it has obtained FDA approval for Juvéderm VOLUMA XC with TSK STERiGLIDE Cannula for cheek enlargement of people 21 years and older. HA dermal fillers are designed to correct the age-related lack of volume in the mid-face. This approval will expand the demand for Juvederm series fillers.
THE MAIN ADVANTAGES OF THE REPORT:
This study introduces an analysis overview of the global dermal filler industry, as well as current trends and future estimates to determine the amount of upcoming investment. The report provides information related to key drivers, constraints, and opportunities, and conducts a detailed analysis to quantitatively analyze the current market from 2022-2030 to highlight the growth of the dermal filler market. Porter’s Five Forces Analysis explains the buyers and suppliers in the dermal filler market. The report provides a detailed dermal filler market analysis based on the intensity of competition and how competition will form in the next few years."
Allergan, Galderma, Merz Aesthetics, Advanced Aesthetics Technologies, Suneva Medical, AQTIS Medical, Teoxane Laboratories, Bioha Laboratories, Dr. Korman Laboratories Ltd., and Laboratoires Vivacy.
Related Reports
Proof of Quality & Reliability
